Related Experiment Video
Updated: Feb 15, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Oxidative burden in familial hypercholesterolemia
Hamid Mollazadeh1,2, Federico Carbone3, Fabrizio Montecucco3,4,5
1Department of Physiology and Pharmacology, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Insights
Familial hypercholesterolemia (FH) causes high LDL cholesterol, accelerating atherosclerosis. Targeting oxidative stress (OS) may reduce this cardiovascular risk in FH patients.
Area of Science:
- Cardiovascular Science
- Genetics
- Biochemistry
Background:
- Familial hypercholesterolemia (FH) is a genetic disorder causing high LDL cholesterol (LDL-c).
- FH accelerates atherosclerosis and is a leading hereditary cause of premature coronary heart disease.
- Mutations in the LDL receptor gene are the hallmark of FH, leading to elevated circulating LDLs.
Purpose of the Study:
- To review the pathophysiological mechanisms linking FH to reactive oxygen species (ROS) generation.
- To update knowledge on the detrimental impact of ROS on atherosclerotic pathophysiology in FH.
- To examine the role of oxidative stress (OS) in FH-related inflammation and atherosclerosis.
Main Methods:
- Narrative review of experimental and clinical data.
- Analysis of the association between FH and OS.
- Evaluation of OS as a promoter of inflammation and atherosclerosis.
Main Results:
- FH promotes ROS generation, a key factor in atherosclerosis development.
- Oxidized LDL, malondialdehyde, ROS, and isoprostanes are key mediators of oxidative injury in FH.
- Oxidative stress plays a significant role in FH-related inflammation and atherogenesis.
Conclusions:
- Targeting oxidative stress presents a promising therapeutic strategy for reducing atherogenesis in FH patients.
- Understanding the link between FH, ROS, and atherosclerosis is crucial for developing new treatments.
Abstract:
Familial hypercholesterolemia (FH) is a genetic disorder characterized by high serum levels of low-density lipoprotein cholesterol (LDL-c). FH is characterized by accelerated development of atherosclerosis and represents the most frequent hereditary cause of premature coronary heart disease. Mutations of the LDL receptor gene are the genetic signature of FH, resulting in abnormal levels of circulating LDLs. Moreover, FH promotes the generation of reactive oxygen species (ROS) which is another key mechanism involved in atherosclerosis development and progression. The aim of this narrative review is to update the current knowledge on the pathophysiological mechanisms linking FH to ROS generation and their detrimental impact on atherosclerotic pathophysiology. With this purpose, we reviewed experimental and clinical data on the association between FH and OS and the functional role of OS as a promoter of inflammation and atherosclerosis. In this regard, oxidant species such as oxidized LDL, malondialdehyde, ROS, and isoprostanes emerged as leading mediators of the oxidative injury in FH. In conclusion, targeting oxidative stress may be a promising therapeutic strategy to reduce atherogenesis in patients with FH.
Related Concept Videos
Protein Families
Protein Families
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Gene Families
Family Therapy
Strategic Family Therapy
Strategic family therapy emphasizes resolving communication barriers and improving problem-solving abilities...
Oxidation Numbers

